The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Andreev D.A.

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

Kamynina N.N.

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

Key specific tools for assessment of life quality of patients with psoriasis

Authors:

Andreev D.A., Kamynina N.N.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2025;24(3): 319‑325

DOI: 10.17116/klinderma202524031319

Read: 795 times

Buy for 300₽
Contact the author
Table of contents

KEY SPECIFIC TOOLS FOR ASSESSMENT OF LIFE QUALITY OF PATIENTS WITH PSORIASIS
KEY SPECIFIC TOOLS FOR ASSESSMENT OF LIFE QUALITY OF PATIENTS WITH PSORIASIS

To cite this article:

Andreev DA, Kamynina NN. Key specific tools for assessment of life quality of patients with psoriasis. Russian Journal of Clinical Dermatology and Venereology. 2025;24(3):319‑325. (In Russ.)
https://doi.org/10.17116/klinderma202524031319

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177
Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xero­sis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):178-184
Clinical effi­cacy of high-intensity magnetic therapy and transcutaneous electrical nerve stimulation in patients with diabetes mellitus and distal poly­neuropathy: a randomized study. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(1):5-11
Effi­cacy and safety of mome­tasone and olopatadine combination for nasal use in patients with alle­rgic rhinitis caused by sensitization to epidermal alle­rgens in continuous expo­sure. Russian Rhinology. 2025;(1):48-56
Treatment of acute hemo­rrhoids acco­rding to the resu­lts of a multicenter obse­rvational study. Piro­gov Russian Journal of Surgery. 2025;(3):112-123
Vali­dation of the Russian version of the Caro­linas Comfort Scale in patients after previous abdo­minal hernia repair with mesh. Piro­gov Russian Journal of Surgery. 2025;(4):30-30
Prediction and prevention of burnout syndrome in health care professionals in high epidemic risk settings. Russian Journal of Preventive Medi­cine. 2025;(4):51-56
The effect of a gami­fication on healthy indi­viduals’ motor acti­vity. Russian Journal of Preventive Medi­cine. 2025;(4):111-116
Analysis of the oral health-related quality of life among school children and young adults before and after orthodontic treatment. Stomatology. 2025;(2):54-58
Abstract:

INTRODUCTION

Influence of psoriasis on the patient’s psychological status and quality of life is taken into account in the recommendations for achieving the target indicators of therapy. The use of highly specific tools allows to obtain detailed estimates of patients’ life quality.

OBJECTIVE

To search and generalize the foreign data on the characteristics and modern examples of specific tools for monitoring life quality application in psoriasis.

MATERIAL AND METHODS

The study was performed in accordance with an analysis of data about specific tools presented in the PubMed bibliographic database.

RESULTS

Characteristics and application of specific questionnaires are considered: the questionnaire for assessment of psoriasis symptoms (PSI), the quality of life index in psoriasis (PSORIQoL), the questionnaire for evaluation of psoriasis impact (IPSO), the index of disability in psoriasis (PDI), the inventory for assessment of stress level in psoriasis (PLSI), the Salford index of psoriasis severity (SPI), the 12-item quality of life questionnaire in psoriasis (PQoL-12), the simplified scale for self-assessment of psoriasis severity (SaSPI).

DISCUSSION

Selection and use of optimal questionnaires are an important step towards determining the effectiveness of pharmacological interventions, developing working programs of individual counselling and patients’ education.

Keywords:

psoriasis
quality of life
inventories
questionnaires
specific tools

Authors:

Andreev D.A.

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

Kamynina N.N.

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

Received:

19.12.2024

Accepted:

06.03.2025

Close metadata

References:

  1. Nowowiejska J, Baran A, Flisiak I. Mutual Relationship Between Sleep Disorders, Quality of Life and Psychosocial Aspects in Patients With Psoriasis. Front Psychiatry. 2021;12:674460. https://doi.org/10.3389/fpsyt.2021.674460
  2. Karpińska-Mirecka A, Bartosińska J, Krasowska D. The effects of selected biologics and a small molecule on Health-Related Quality of Life in adult plaque psoriasis patients: A systematic review and meta-analysis. PLoS One. 2020;15:e0241604. https://doi.org/10.1371/journal.pone.0241604
  3. de Carvalho AVE, Romiti R, da Souza CS, Paschoal RS, de Milman LM, Meneghello LP. Psoriasis comorbidities: complications and benefits of immunobiological treatment. An Bras Dermatol. 2016;91:781-789.  https://doi.org/10.1590/abd1806-4841.20165080
  4. Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CEM, Nast A, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011;303:1-10.  https://doi.org/10.1007/s00403-010-1080-1
  5. Reich A, Szepietowski J, Adamski Z, Chodorowska G, Kaszuba A, Krasowska D, et al. Psoriasis. Diagnostic and therapeutic recommendations of the polish dermatological society. Part II: Moderate to severe psoriasis. Przegl Dermatol. 2018;105:329-357. 
  6. Andreev DA, Kamynina NN. Properties and application of the dermatological index for assessing the quality of life in patients with psoriasis. Zdorov’e Megapolisa. 2023;4:122-134. (In Russ.). https://doi.org/10.47619/2713-2617.zm.2023.v.4i4;122-134
  7. Ghezzi G, Costanzo A, Borroni RG. Health-Related Quality of Life in Psoriasis: Literature Review. J Clin Med. 2024;13:4623. https://doi.org/10.3390/jcm13164623
  8. Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res an Int J Qual Life Asp Treat Care Rehabil. 2018;27: 1147-1157. https://doi.org/10.1007/s11136-018-1798-3
  9. Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Qual Life Res an Int J Qual Life Asp Treat Care Rehabil. 2018;27:1171-1179. https://doi.org/10.1007/s11136-017-1765-4
  10. Martin ML, McCarrier KP, Chiou C-F, Gordon K, Kimball AB, Van Voorhees AS, et al. Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity. J Dermatolog Treat. 2013;24:255-260.  https://doi.org/10.3109/09546634.2012.759639
  11. McKenna SP, Cook SA, Whalley D, Doward LC, Richards HL, Griffiths CEM, et al. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol. 2003;149:323-331.  https://doi.org/10.1046/j.1365-2133.2003.05492.x
  12. Pérez-Chada LM, Hopkins ZH, Balak DMW, Rashid S, Creadore A, Chu B, et al. Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic Review. JAMA Dermatology. 2024;160:550-563.  https://doi.org/10.1001/jamadermatol.2023.5439
  13. Nijsten T, Unaeze J, Stern RS. Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis. Br J Dermatol. 2006;154:692-700.  https://doi.org/10.1111/j.1365-2133.2005.07066.x
  14. Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27: 1159-1170. https://doi.org/10.1007/s11136-018-1829-0
  15. Finlay AY, Kelly SE. Psoriasis‐an index of disability. Clin Exp Dermatol. 1987;12:8-11.  https://doi.org/10.1111/j.1365-2230.1987.tb01844.x
  16. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol. 1995;75:240-243.  https://doi.org/10.2340/0001555575240243
  17. Kirby B, Fortune DG, Bhushan M, Chalmers RJ, Griffiths CE. The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol. 2000;142:728-732.  https://doi.org/10.1046/j.1365-2133.2000.03418.x
  18. Koo J, Kozma CM, Reinke K. The Development of a Disease-Specific Questionnaire to Assess Quality of Life for Psoriasis Patients: An Analysis of the Reliability, Validity, and Responsiveness of the Psoriasis Quality of Life Questionnaire. Dermatology Psychosom/Dermatologie Und Psychosom. 2003; 3:171-179.  https://doi.org/10.1159/000069253
  19. Mühleisen B, Büchi S, Schmidhauser S, Jenewein J, French LE, Hofbauer GFL. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients. Arch Dermatol. 2009;145:774-780.  https://doi.org/10.1001/archdermatol.2009.121
  20. Bushnell DM, Martin ML, McCarrier K, Gordon K, Chiou C-F, Huang X, et al. Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity. J Dermatolog Treat. 2013;24:356-360.  https://doi.org/10.3109/09546634.2012.742950
  21. Rigopoulos D, Tampouratzi E, Angelakopoulos C, Apalla Z, Barkis I, Georgiou S, et al. Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study). J Eur Acad Dermatology Venereol. 2024;38:1121-1130. https://doi.org/10.1111/jdv.19816
  22. Boswell ND, Cook MK, Balogh EA, Feldman SR. The impact of complete clearance and almost complete clearance of psoriasis on quality of life: a literature review. Arch Dermatol Res. 2023;315:699-706.  https://doi.org/10.1007/s00403-022-02420-5
  23. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35.  https://doi.org/10.1186/1477-7525-4-35
  24. Bronsard V, Paul C, Prey S, Puzenat E, Gourraud P-A, Aractingi S, et al. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol. 2010;24(2):17-22.  https://doi.org/10.1111/j.1468-3083.2009.03563.x
  25. Mease PJ, Menter MA. Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol. 2006;54:685-704.  https://doi.org/10.1016/j.jaad.2005.10.008
  26. Mihu C, Popescu CA, Neag MA, Bocşan IC, Melincovici CS, Baican AL, et al. The Psoriasis Disability Index in Romanian Psoriasis Patients during COVID-19 Pandemic: Contribution of Clinical and Psychological Variables. J Clin Med. 2023;12: without pages. https://doi.org/10.3390/jcm12186000
  27. Papp KA, Beyska‐Rizova S, Gantcheva ML, Slavcheva Simeonova E, Brezoev P, Celic M, et al. Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT-1). J Eur Acad Dermatology Venereol. 2024;38:1112-1120. https://doi.org/10.1111/jdv.19811
  28. Nishat F, Bhuiyan MSI, Khan MA, Jesmin A, Khan MAS, Hasan MJ. Cross-cultural adaptation and validation of the Bangla version of the Psoriasis Disability Index. J Public Health Res. 2023;12:22799036231181204. https://doi.org/10.1177/22799036231181205
  29. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol. 1995;75:240-243.  https://doi.org/10.2340/0001555575240243
  30. Park SY, Kim KH. What Factors Influence on Dermatology-Related Life Quality of Psoriasis Patients in South Korea? Int J Environ Res Public Health. 2021;18:without pages. https://doi.org/10.3390/ijerph18073624
  31. Nagarajan P, Thappa DM. Effect of an Educational and Psychological Intervention on Knowledge and Quality of Life among Patients with Psoriasis. Indian Dermatol Online J. 2018;9:27-32.  https://doi.org/10.4103/idoj.IDOJ_111_17
  32. Chularojanamontri L, Griffiths CEM, Chalmers RJG. The Simplified Psoriasis Index (SPI): A Practical Tool for Assessing Psoriasis. J Invest Dermatol. 2013;133:1956-1962. https://doi.org/10.1038/jid.2013.138
  33. Yosipovitch G, Tang MBY. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options. Drugs Aging. 2002;19:847-863.  https://doi.org/10.2165/00002512-200219110-00003
  34. Koo JYM, Menter A. The Koo-Menter Psoriasis Instrument for Identifying Candidate Patients for Systemic Therapy. Psoriasis Forum. 2003;9a:6-9.  https://doi.org/10.1177/247553030309a00205
  35. Heller MM, Wong JW, Nguyen T V, Lee ES, Bhutani T, Menter A, et al. Quality-of-Life Instruments: Evaluation of the Impact of Psoriasis on Patients. Dermatol Clin. 2012;30:281-291.  https://doi.org/10.1016/j.det.2011.11.006
  36. Menter MA, Caveney SW, Gottschalk RW. Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis. J Drugs Dermatol. 2012;11:1348–1354.
  37. Feldman SR, Koo JYM, Menter A, Bagel J. Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol. 2005;53:101-107.  https://doi.org/10.1016/j.jaad.2005.03.050
  38. Soliman M. Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey. Clin Cosmet Investig Dermatol. 2020;13:601-609.  https://doi.org/10.2147/CCID.S269909
  39. Fotiou K, Hofmann M, Kaufmann R, Thaci D. Pictorial representation of illness and self measure (PRISM): an effective tool to assess the burden of psoriasis. J Eur Acad Dermatol Venereol. 2015;29:2356-2362. https://doi.org/10.1111/jdv.13232
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.